Reprogramming of host glutamine metabolism during Chlamydia trachomatis infection and its key role in peptidoglycan synthesis

Karthika Rajeeve,Nadine Vollmuth,Sudha Janaki-Raman,Thomas F. Wulff,Apoorva Baluapuri,Francesca R. Dejure,Claudia Huber,Julian Fink,Maximilian Schmalhofer,Werner Schmitz,Rajeeve Sivadasan,Martin Eilers,Elmar Wolf,Wolfgang Eisenreich,Almut Schulze,Jürgen Seibel,Thomas Rudel
DOI: https://doi.org/10.1038/s41564-020-0762-5
IF: 28.3
2020-08-03
Nature Microbiology
Abstract:Obligate intracellular bacteria such as <i>Chlamydia trachomatis</i> undergo a complex developmental cycle between infectious, non-replicative elementary-body and non-infectious, replicative reticulate-body forms. Elementary bodies transform to reticulate bodies shortly after entering a host cell, a crucial process in infection, initiating chlamydial replication. As <i>Chlamydia</i> fail to replicate outside the host cell, it is unknown how the replicative part of the developmental cycle is initiated. Here we show, using a cell-free approach in axenic media, that the uptake of glutamine by the bacteria is crucial for peptidoglycan synthesis, which has a role in <i>Chlamydia</i> replication. The increased requirement for glutamine in infected cells is satisfied by reprogramming the glutamine metabolism in a c-Myc-dependent manner. Glutamine is effectively taken up by the glutamine transporter SLC1A5 and metabolized via glutaminase. Interference with this metabolic reprogramming limits the growth of <i>Chlamydia</i>. Intriguingly, <i>Chlamydia</i> failed to produce progeny in SLC1A5-knockout organoids and mice. Thus, we report on the central role of glutamine for the development of an obligate intracellular pathogenic bacterium and the reprogramming of host glutamine metabolism, which may provide a basis for innovative anti-infection strategies.
microbiology
What problem does this paper attempt to address?